Anturan for secondary prophylaxis of myocardial infarction.
273 patients suffering from ischemic heart disease were treated with Anturan for one year at a daily dosage of 800 mg. The number of cardiovascular complications was significantly reduced, compared to the control group.
Bokarev
I N
IN
Department of Internal Medicine, Lumumba University, USSR.
Lusov
V A
VA
Golikov
A P
AP
Ptushkin
V V
VV
Zvereva
T V
TV
Savenkov
M P
MP
Seregina
M V
MV
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005960:Glucosides / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D013442:Sulfinpyrazone / Q000008:administration & dosage / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D005960:Glucosides; D013442:Sulfinpyrazone